AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 182 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $29,561,809 | -60.4% | 4,655,403 | -62.2% | 9.98% | -57.1% |
| Q1 2024 | $74,624,343 | -42.9% | 12,314,248 | -42.8% | 23.25% | -12.7% |
| Q4 2023 | $130,634,297 | +43.8% | 21,521,301 | 0.0% | 26.62% | +82.6% |
| Q3 2023 | $90,819,890 | +36.1% | 21,521,301 | 0.0% | 14.58% | +55.9% |
| Q2 2023 | $66,716,032 | +123.0% | 21,521,301 | 0.0% | 9.35% | +232.2% |
| Q1 2023 | $29,914,609 | -30.2% | 21,521,301 | 0.0% | 2.82% | -20.0% |
| Q4 2022 | $42,827,417 | -1.5% | 21,521,301 | 0.0% | 3.52% | -24.3% |
| Q3 2022 | $43,473,000 | -36.5% | 21,521,301 | 0.0% | 4.65% | -51.0% |
| Q2 2022 | $68,438,000 | -23.7% | 21,521,301 | 0.0% | 9.48% | +22.4% |
| Q1 2022 | $89,744,000 | -12.9% | 21,521,301 | 0.0% | 7.75% | +31.5% |
| Q4 2021 | $103,087,000 | -10.3% | 21,521,301 | 0.0% | 5.89% | +0.2% |
| Q3 2021 | $114,924,000 | +4.3% | 21,521,301 | 0.0% | 5.88% | -10.1% |
| Q2 2021 | $110,189,000 | -23.9% | 21,521,301 | 0.0% | 6.54% | -42.6% |
| Q1 2021 | $144,839,000 | +47.3% | 21,521,301 | 0.0% | 11.40% | +77.5% |
| Q4 2020 | $98,351,000 | +17.8% | 21,521,301 | 0.0% | 6.42% | -12.4% |
| Q3 2020 | $83,503,000 | -18.5% | 21,521,301 | 0.0% | 7.34% | -25.4% |
| Q2 2020 | $102,442,000 | +36.8% | 21,521,301 | 0.0% | 9.84% | +35.1% |
| Q1 2020 | $74,893,000 | -27.8% | 21,521,301 | 0.0% | 7.28% | -15.6% |
| Q4 2019 | $103,733,000 | +66.2% | 21,521,301 | 0.0% | 8.63% | +24.7% |
| Q3 2019 | $62,412,000 | -55.5% | 21,521,301 | +10.1% | 6.92% | -25.3% |
| Q2 2019 | $140,188,000 | -49.4% | 19,552,001 | 0.0% | 9.26% | -47.4% |
| Q1 2019 | $277,052,000 | +4.7% | 19,552,001 | 0.0% | 17.60% | +11.4% |
| Q4 2018 | $264,539,000 | -39.0% | 19,552,001 | 0.0% | 15.80% | -24.0% |
| Q3 2018 | $433,859,000 | +30.3% | 19,552,001 | -3.7% | 20.80% | +22.3% |
| Q2 2018 | $333,013,000 | – | 20,293,351 | – | 17.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |